Jeffrey B. Jorgensen

University of Louisville, Prisma Health

Papers

2

Total Citations

38

H-Index

2

About

Dr. Jeffrey B. Jorgensen is a leading otolaryngologist and head and neck surgeon whose research focuses on optimizing surgical outcomes in transoral robotic surgery (TORS) for oropharyngeal cancer. His work is pivotal in understanding and mitigating the most serious complication of TORS: postoperative hemorrhage. In his highly cited 2019 systematic review and meta-analysis (34 citations), Dr. Jorgensen provided critical evidence that prophylactic arterial ligation can significantly reduce the severity of major bleeding events, establishing a safer standard of care. He has also advanced the field by investigating patient-specific risk factors; his 2022 national analysis of over 4,000 patients from the National Cancer Database demonstrated how comorbidity scores, such as the Charlson-Deyo index, are independently associated with worse perioperative outcomes following TORS. By combining rigorous meta-analytic techniques with large-scale database research, Dr. Jorgensen’s work directly informs surgical decision-making, helping to identify high-risk patients and refine protocols to improve safety and recovery. His contributions are essential reading for any surgeon or researcher working to enhance the precision and safety of robotic head and neck surgery.

Research Focus

Key Achievements

2
H-Index
2
Papers
38
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Prophylactic arterial ligation following transoral robotic surgery: A systematic review and meta‐analysis
34 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: University of Louisville, Prisma Health

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago